Company profile

Asceneuron SA

Asceneuron develops effective therapeutics for orphan tauopathies such as progressive supranuclear palsy (PSP) and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases. Our first candidate molecule for progressive supranuclear palsy is aimed at preventing the formation of toxic tau aggregates by a groundbreaking molecular mechanism and has the potential to enter Phase 1 clinical trials by mid-2015.

More news about Asceneuron SA

16.10.2023 11:00

Industry leaders to take startups to new heights

Please login or
register to use the
awards follow feature
23.02.2023 09:10

Asceneuron PSP Candidate Treatment rights sold to Ferrer

Please login or
register to use the
awards follow feature
05.05.2022 15:40

Asceneuron obtains grant to advance treatment for Parkinson’s Disease

Please login or
register to use the
awards follow feature
20.07.2021 13:16

Startups welcome legendary board members aboard

Please login or
register to use the
awards follow feature
21.01.2019 17:06

Biotech startups strengthen their teams for the next steps

Please login or
register to use the
awards follow feature
20.07.2018 13:56

Asceneuron’s tau modifier receives Orphan Drug Designation

Please login or
register to use the
awards follow feature
10.04.2017 16:08

Asceneuron Receives Regulatory Approval for Phase I Study

Please login or
register to use the
awards follow feature
30.12.2015 11:24

Asceneuron scoops One Nucleus BioNewsRound Award

Please login or
register to use the
awards follow feature
29.09.2015 15:00

Asceneuron raises CHF 30 million

Please login or
register to use the
awards follow feature
17.04.2015 11:52

Nine hot start-ups, 400 visitors and Joe Jimenez

Please login or
register to use the
awards follow feature
14.04.2015 11:18

USD 325,000 grant for Asceneuron

Please login or
register to use the
awards follow feature
10.10.2012 16:27

Merck Serono Announces the Creation of the Third Spin-Off

Please login or
register to use the
awards follow feature
Asceneuron SA

Founded
2012

Kanton
VD

Homepage

rss